van Veelen Nicole Maria, van de Wall Bryan J M, Hoepelman Ruben J, IJpma Frank F A, Link Björn-Christian, Babst Reto, Groenwold Rolf H H, van der Velde Detlef, Diwersi Nadine, van Heijl Mark, Houwert R Marijn, Beeres Frank J P
Department of Orthopaedic and Trauma Surgery, Luzerner Kantonsspital, Luzern, Switzerland.
Department of Health Sciences and Medicine, University of Lucerne, Luzern, Switzerland.
JMIR Res Protoc. 2024 Feb 13;13:e52917. doi: 10.2196/52917.
Distal radius fractures are the most frequently encountered fractures in Western societies, typically affecting patients aged 50 years and older. Although this is a common injury, the best treatment for these fractures in older patients is still under debate.
This prospective study aims to compare the outcome of operatively and nonoperatively treated distal radius fractures in the older population. Only patients with distal radius fractures for which equipoise regarding the optimal treatment exists will be included.
This prospective international multicenter observational cohort study will be designed as a natural experiment. Natural experiments are observational studies in which treatment allocation is determined by factors outside the control of the investigators but also (largely) independent of patient characteristics. Patients aged 65 years and older with an acute distal radius fracture will be considered for inclusion. Treatment allocation (operative vs nonoperative) will be based on the local preferences of the treating hospital either in Switzerland or the Netherlands. Hence, the process governing treatment allocation resembles that of randomization. Patients will be identified after treatment has been initiated. Based on the radiographs and baseline information of the patient, an expert panel of 6 certified trauma surgeons from 2 regions will provide their treatment recommendation. Only patients for whom the experts disagree on treatment recommendations will ultimately be included in the study (ie, for whom there is a clinical equipoise). For these patients, both operative and nonoperative treatment of distal radius fractures are viable, and treatment choice is predominantly determined by personal or local preference. The primary outcome will be the Patient-Rated Wrist Evaluation score at 12 weeks. Secondary outcomes will include the Physical Activity Score for the Elderly, the EQ questionnaire, pain, the living situation, range of motion, complications, and radiological outcomes. By including outcomes such as living situation and the Physical Activity Score for the Elderly, which are not relevant for younger cohorts, valuable information to tailor treatment to the needs of the older population can be gained. According to the sample size collection, which was based on the minimal important clinical difference of the Patient-Rated Wrist Evaluation, 92 patients will have to be included, with at least 46 patients in each treatment group.
Enrollment began in July 2023 and is expected to continue until summer 2024. The final follow-up will be 2 years after the last patient is included.
Although many trials on this topic have previously been published, there remains an ongoing debate regarding the optimal treatment for distal radius fractures in older patients. This observational study, which will use a fairly new methodological study design, will provide further information on treatment outcomes for older patients with distal radius fractures for which to date equipoise exists regarding the optimal treatment.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/52917.
桡骨远端骨折是西方社会最常见的骨折类型,通常影响50岁及以上的患者。尽管这是一种常见损伤,但老年患者这些骨折的最佳治疗方法仍存在争议。
本前瞻性研究旨在比较老年人群中手术治疗和非手术治疗桡骨远端骨折的结果。仅纳入在最佳治疗方案上存在 equipoise 的桡骨远端骨折患者。
本前瞻性国际多中心观察性队列研究将设计为一项自然实验。自然实验是一种观察性研究,其中治疗分配由研究者无法控制但(很大程度上)独立于患者特征的因素决定。将考虑纳入65岁及以上急性桡骨远端骨折的患者。治疗分配(手术与非手术)将基于瑞士或荷兰治疗医院的当地偏好。因此,治疗分配过程类似于随机化。在治疗开始后将识别患者。根据患者的X线片和基线信息,来自2个地区的6名认证创伤外科医生组成的专家小组将提供他们的治疗建议。只有专家在治疗建议上存在分歧的患者最终才会被纳入研究(即存在临床 equipoise 的患者)。对于这些患者,桡骨远端骨折的手术和非手术治疗都是可行的,治疗选择主要由个人或当地偏好决定。主要结局将是12周时的患者自评腕关节评估评分。次要结局将包括老年人身体活动评分、EQ问卷、疼痛、生活状况、活动范围、并发症和影像学结局。通过纳入生活状况和老年人身体活动评分等与年轻队列无关的结局,可以获得根据老年人群需求定制治疗的有价值信息。根据基于患者自评腕关节评估的最小重要临床差异进行的样本量计算,将需要纳入92名患者,每个治疗组至少46名患者。
入组于2023年7月开始,预计持续至2024年夏季。最后一名患者入组后2年进行最终随访。
尽管此前已发表了许多关于该主题的试验,但老年患者桡骨远端骨折的最佳治疗方法仍存在争议。这项观察性研究将采用一种相当新的方法学研究设计,将为最佳治疗方案至今仍存在 equipoise 的老年桡骨远端骨折患者的治疗结局提供进一步信息。
国际注册报告标识符(IRRID):DERR1-10.2196/52917。